BR112018071492A2 - extratos de saxifraga para uso cosmético e terapêutico na pele - Google Patents

extratos de saxifraga para uso cosmético e terapêutico na pele

Info

Publication number
BR112018071492A2
BR112018071492A2 BR112018071492-5A BR112018071492A BR112018071492A2 BR 112018071492 A2 BR112018071492 A2 BR 112018071492A2 BR 112018071492 A BR112018071492 A BR 112018071492A BR 112018071492 A2 BR112018071492 A2 BR 112018071492A2
Authority
BR
Brazil
Prior art keywords
skin
saxifraga
cosmetic
extracts
therapeutic use
Prior art date
Application number
BR112018071492-5A
Other languages
English (en)
Inventor
Mutel Vincent
Simonnet Xavier
Schnyder Bruno
Original Assignee
Tauderma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tauderma Sa filed Critical Tauderma Sa
Publication of BR112018071492A2 publication Critical patent/BR112018071492A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783—Angiosperms [Magnoliophyta]
    • A61K8/9789—Magnoliopsida [dicotyledons]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30—Extraction of the material
    • A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
    • A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30—Extraction of the material
    • A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
    • A61K2236/333—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using mixed solvents, e.g. 70% EtOH
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/74—Biological properties of particular ingredients
    • A61K2800/78—Enzyme modulators, e.g. Enzyme agonists
    • A61K2800/782—Enzyme inhibitors; Enzyme antagonists

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Medical Informatics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Birds (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

a presente invenção refere-se a um extrato obtido a partir de saxifraga sp., astrantia major, ou uma combinação dos mesmos dos mesmos e um método para tratar ou aliviar uma condição inflamatória relacionada com a pele em um indivíduo. o método compreende administrar ou aplicar uma composição compreendendo uma quantidade eficaz de um extrato de saxifraga sp., astrantia major ou uma combinação dos mesmos e um veículo, onde a quantidade eficaz do extrato inibe o fator alfa de necrose tumoral e a atividade de interleucina-1beta. a inflamação pode ser inflamação da pele e a composição pode ser uma preparação para a pele para uso externo.
BR112018071492-5A 2016-05-03 2017-05-03 extratos de saxifraga para uso cosmético e terapêutico na pele BR112018071492A2 (pt)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201662331236P 2016-05-03 2016-05-03
US62/331,236 2016-05-03
US201662356327P 2016-06-29 2016-06-29
US62/356,327 2016-06-29
PCT/IB2017/052579 WO2017191581A1 (en) 2016-05-03 2017-05-03 Saxifraga extracts for cosmetic or therapeutic use on the skin

Publications (1)

Publication Number Publication Date
BR112018071492A2 true BR112018071492A2 (pt) 2019-02-19

Family

ID=58873843

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112018071492-5A BR112018071492A2 (pt) 2016-05-03 2017-05-03 extratos de saxifraga para uso cosmético e terapêutico na pele

Country Status (11)

Country Link
US (1) US10813962B2 (pt)
EP (1) EP3452176B1 (pt)
JP (1) JP7016171B2 (pt)
KR (1) KR102443662B1 (pt)
CN (1) CN109152938A (pt)
AU (1) AU2017259057B2 (pt)
BR (1) BR112018071492A2 (pt)
CA (1) CA3023031A1 (pt)
ES (1) ES2883168T3 (pt)
RU (1) RU2018142385A (pt)
WO (1) WO2017191581A1 (pt)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109663020A (zh) * 2019-02-25 2019-04-23 广西中医药大学 一种治疗痒风的瑶药组合物及其应用
WO2022092124A1 (ja) * 2020-10-28 2022-05-05 国立大学法人神戸大学 マトリックスメタロプロテアーゼ１発現抑制剤、皮膚外用剤、及びマトリックスメタロプロテアーゼ１発現抑制のための使用
CN113087608B (zh) * 2021-03-08 2022-11-11 中国科学院西北高原生物研究所 唐古特虎耳草中新的二芳基壬烷类ⅴ，ⅵ和ⅶ自由基抑制剂及其分离制备工艺和应用
CN113087606B (zh) * 2021-03-08 2022-11-11 中国科学院西北高原生物研究所 唐古特虎耳草中新的二芳基壬烷类ⅳ和ⅲ自由基抑制剂及其分离制备工艺和应用
KR20220168080A (ko) * 2021-06-15 2022-12-22 김종완 자화지정과 호이초 추출물을 유효 성분으로 함유하는 벌레물림 및 피부질환 치료제
CN113786421A (zh) * 2021-10-25 2021-12-14 北京农学院 一种具有抗炎活性的虎耳草提取物及其制备方法和应用

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH09136823A (ja) * 1995-11-15 1997-05-27 Shiseido Co Ltd 抗老化皮膚外用剤、コラーゲン架橋阻害皮膚外用剤及び抗紫外線皮膚外用剤
FR2795639B1 (fr) * 1999-07-02 2001-09-21 Oreal Compositions pour la coloration artificielle de la peau et utilisations
AU2002229074A1 (en) 2000-12-15 2002-06-24 Pharmacia Corporation Selective cox-2 inhibition from plant extracts
CN1164286C (zh) * 2001-02-28 2004-09-01 吴战惠 消炎止痛祛毒外用药液及其制备方法
WO2002102396A1 (fr) * 2001-06-15 2002-12-27 Kyowa Hakko Kogyo Co., Ltd. Agents de prévention ou remèdes destinés à l'arthrite
JP2006510592A (ja) 2002-09-11 2006-03-30 エスケー ケミカルズ カンパニー リミテッド スイカズラ（ＬｏｎｉｃｅｒａｊａｐｏｎｉｃａＴｈｕｎｂ．）茎の活性成分の抽出および精製方法、その消炎鎮痛剤への用途
WO2007128558A1 (en) 2006-04-28 2007-11-15 Bayer Cropscience Ag Method for separating off coloring components from aqueous plant extracts
WO2009082511A1 (en) * 2007-12-20 2009-07-02 Elc Management Llc Methods and compositions for treating skin
ES2548867T3 (es) 2009-03-20 2015-10-21 Bioxtract S.A. Composición farmacéutica que presenta propiedades antiinflamatorias y antihistamínicas
EP2564830B1 (en) * 2010-04-27 2017-11-01 Kao Corporation Aqueous composition contained in container
CN103561754A (zh) 2011-03-28 2014-02-05 玫琳凯有限公司 包含植物提取物的局部护肤制剂
US9763873B2 (en) * 2013-08-16 2017-09-19 La Prairie Group Ag Preparation for protecting against extrinsic and intrinsic skin aging
KR20150125241A (ko) * 2014-04-30 2015-11-09 (주)아모레퍼시픽 산형화 추출물을 포함하는 조성물

Also Published As

Publication number Publication date
JP7016171B2 (ja) 2022-02-21
CN109152938A (zh) 2019-01-04
US10813962B2 (en) 2020-10-27
KR102443662B1 (ko) 2022-09-15
WO2017191581A1 (en) 2017-11-09
RU2018142385A (ru) 2020-06-03
KR20190013779A (ko) 2019-02-11
US20190160124A1 (en) 2019-05-30
CA3023031A1 (en) 2017-11-09
RU2018142385A3 (pt) 2020-08-10
EP3452176A1 (en) 2019-03-13
JP2019514981A (ja) 2019-06-06
AU2017259057A1 (en) 2018-11-01
AU2017259057B2 (en) 2022-05-12
ES2883168T3 (es) 2021-12-07
EP3452176B1 (en) 2021-06-23

Similar Documents

Publication Publication Date Title
BR112018071492A2 (pt) extratos de saxifraga para uso cosmético e terapêutico na pele
CO2019006291A2 (es) Composiciones de aminoácidos y métodos de tratamiento de enfermedades hepáticas
BR112017015059A2 (pt) inibidor de proteassoma e uso
BR112019000598A2 (pt) rna para terapia de câncer
BR112013014021A8 (pt) Métodos para tratamento de calvície e promoção de crescimento de cabelos
BR112018005110A2 (pt) Composição emoliente e sua utilização cosmética, composição cosmética, dermatológica ou farmacêutica e sua utilização cosmética e processo de tratamento cosmético da pele
BR112015019440A8 (pt) curativo regulável, kit, uso e método para fortalecimento da pele
BR112015027282A8 (pt) formulação líquida e kit compreendendo fenfluramina, e usos da mesma no tratamento de síndrome de dravet
BR112021016296A2 (pt) Formulações tópicas de rapamicina e seu uso em tratamento de angiofibromas faciais e outros distúrbios de pele
BR112015010477A2 (pt) combinação farmacêutica que compreende um inibidor b-raf e um inibidor de histona desacetilase e o uso dos mesmos no tratamento de doenças proliferativas
BR112015010772A2 (pt) composição de enxágue tópica, uso de uma composição e método para tratar ou melhorar a pele de um indivíduo contra a acne
BR112016000335A8 (pt) método de tratamento da rosácea papulopustular, de tratamento de lesões inflamatórias da rosácea papulopustular e uso de uma composição farmacêutica
BR112018005905A2 (pt) ?composto, composição farmacêutica, métodos para evitar ou tratar uma doença ou condição, lesões de órgão, hepatotoxicidade e fígado gorduroso, e, uso de um composto?
BR112017017448A2 (pt) métodos e composições para o tratamento de doença do olho ressecado e outros distúrbios do olho
BRPI0810336A2 (pt) "método para tratar e/ou prevenir úlceras de pele em um indivíduo"
BR112015000776A2 (pt) Agentes de ligação à rspo3 e usos dos mesmos
MX366502B (es) Composiciones y métodos para tratar heridas superficiales.
BR112013010556A2 (pt) métodos e composições adequadas para a promoção de uma pele saudável
BR112015026247A2 (pt) métodos para o tratamento de câncer com o uso de terapia combinada com inibidor de cinase tor
BR112015014532A2 (pt) composições cosméticas de fluido de eclosão de peixe
BR112012026875A2 (pt) uso de eclipta prostrata e outros inibidores ppar-gamma em cosméticos e suas composições.
BR112017007748A2 (pt) “composição farmacêutica, agente antialérgico, composição alimentar, composição cosmética, uso de um extrato, e, método para prevenir ou tratar uma doença alérgica
CL2018003214A1 (es) Composiciones cosméticas prebióticas y uso de las composiciones cosméticas prebióticas
BR112013018365A2 (pt) "peptídeos derivados da lactoferrina humana, uso dos mesmos e composição farmacêutica"
BR112017027897A2 (pt) usos terapêuticos das formulações de berberina

Legal Events

Date Code Title Description
B06W Patent application suspended after preliminary examination (for patents with searches from other patent authorities) chapter 6.23 patent gazette]
B350 Update of information on the portal [chapter 15.35 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL.MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL.